Estonie - estonien - Ravimiamet

b. braun melsungen ag - neostigmiin+glükopürroonium - süstelahus - 2,5mg+0,5mg 1ml 1ml 10tk

Estonie - estonien - Ravimiamet

b. braun melsungen ag - süstevesi - süsteravimi lahusti - 1000ml 1tk

Estonie - estonien - Ravimiamet

b. braun melsungen ag - etomidaat - süsteemulsioon - 2mg 1ml 10ml 10tk

Union européenne - estonien - EMA (European Medicines Agency)

resilience biomanufacturing ireland limited - antigeen, mis sisaldab: a / vietnam / 1203/2004 (h5n1), gripivaktsiin (kogu virion, inaktiveeritud) - influenza, human; immunization; disease outbreaks - vaktsiinid - gripi profülaktika ametlikult pandeemia korral. pandeemilise gripi vaktsiini tuleks kasutada vastavalt ametlikele juhistele.

Estonie - estonien - Ravimiamet

b.braun medical, s.a. - gentamütsiin - infusioonilahus - 3mg 1ml 80ml 10tk

Estonie - estonien - Ravimiamet

b.braun medical, s.a. - gentamütsiin - infusioonilahus - 1mg 1ml 80ml 10tk

Estonie - estonien - Ecolab

ecolab deutschland gmbh -

Union européenne - estonien - EMA (European Medicines Agency)

takeda manufacturing austria ag - inimese valk c - purpura fulminans; protein c deficiency - antitrombootilised ained - ceprotin is indicated for prophylaxis and treatment of  purpura fulminans  coumarin-induced skin necrosis and venous thrombotic events in patients with severe congenital protein c deficiency.

Union européenne - estonien - EMA (European Medicines Agency)

acino ag - klopidogreel - peripheral vascular diseases; acute coronary syndrome; myocardial infarction; stroke - antitrombootilised ained - clopidogrel is indicated in adults for the prevention of atherothrombotic events in: , , , patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease, non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa), st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy, patients suffering from acute coronary syndrome. , ,.

Union européenne - estonien - EMA (European Medicines Agency)

bayer ag - octocog alfa - hemofiilia a. - antihemorraagilised ained - verejooksu ravi ja profülaktika hemofiilia a patsientidel (kaasasündinud viii faktori puudulikkus). iblias võib kasutada kõikides vanuserühmades.